"Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer," The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat advanced or recurrent forms of the disease. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news